What is more exciting? The activity of docetaxel in early prostate cancer or the successful collaboration between urologists and medical oncologists to complete a study in early prostate cancer?

Research output: Contribution to journalEditorialpeer-review

Fingerprint Dive into the research topics of 'What is more exciting? The activity of docetaxel in early prostate cancer or the successful collaboration between urologists and medical oncologists to complete a study in early prostate cancer?'. Together they form a unique fingerprint.